These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34329710)

  • 21. Inclusion of the Phytoalexin
    Catenacci L; Sorrenti M; Bonferoni MC; Hunt L; Caira MR
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32102298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First-time oral administration of resveratrol-loaded layer-by-layer nanoparticles to rats - a pharmacokinetics study.
    Santos AC; Veiga FJ; Sequeira JAD; Fortuna A; Falcão A; Pereira I; Pattekari P; Fontes-Ribeiro C; Ribeiro AJ
    Analyst; 2019 Mar; 144(6):2062-2079. PubMed ID: 30724915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol.
    Chimento A; De Amicis F; Sirianni R; Sinicropi MS; Puoci F; Casaburi I; Saturnino C; Pezzi V
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30893846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics, efficacy, and safety evaluation of docetaxel/hydroxypropyl-sulfobutyl-β-cyclodextrin inclusion complex.
    Huang XX; Zhou CL; Wang H; Chen C; Yu SQ; Xu Q; Zhu YY; Ren Y
    AAPS PharmSciTech; 2011 Jun; 12(2):665-72. PubMed ID: 21584856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and molecular modeling of the inclusion complexes of 2-(2-nitrovinyl) furan (G-0) with cyclodextrines.
    Ruz V; Froeyen M; Busson R; González MM; Baudemprez L; Van den Mooter G
    Int J Pharm; 2012 Dec; 439(1-2):275-85. PubMed ID: 22989977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inclusion Complex of Isoliquiritigenin With Sulfobutyl Ether-β-Cyclodextrin: Preparation, Characterization, Inclusion Mode, Solubilization, and Stability.
    Wu X; Li J; Hu C; Zheng Y; Zhang Y; Li J; Li M; Xiao D; Lu L; Huang Y; Zhang X; Li C
    Front Chem; 2022; 10():930297. PubMed ID: 35800032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulatory Effects of Soluplus® on Flufenamic Acid β-Cyclodextrin Supramolecular Complex: Physicochemical Characterization and Pre-clinical Anti-inflammatory Assessment.
    Alshehri S; Imam SS; Altamimi MA; Hussain A; Shakeel F; Alshehri A
    AAPS PharmSciTech; 2020 May; 21(5):145. PubMed ID: 32430787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solubilization of vorinostat by cyclodextrins.
    Cai YY; Yap CW; Wang Z; Ho PC; Chan SY; Ng KY; Ge ZG; Lin HS
    J Clin Pharm Ther; 2010 Oct; 35(5):521-6. PubMed ID: 20831676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxypropyl-sulfobutyl-β-cyclodextrin improves the oral bioavailability of edaravone by modulating drug efflux pump of enterocytes.
    Rong WT; Lu YP; Tao Q; Guo M; Lu Y; Ren Y; Yu SQ
    J Pharm Sci; 2014 Feb; 103(2):730-42. PubMed ID: 24311389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
    Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
    Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
    Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
    Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
    Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
    Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
    Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.
    Bourkaib N; Zhou J; Yao J; Fang Z; Mezghrani O
    Drug Dev Ind Pharm; 2013 Jun; 39(6):918-27. PubMed ID: 22998295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin.
    Lu Y; Zhang T; Tao J; Ji G; Wang S
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1452-9. PubMed ID: 19929204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing a potential in vivo drug-excipient interaction: temporal effects of a modified β-cyclodextrin on the intravenous pharmacokinetics of a model high-affinity drug ligand.
    Mannila A; Morizzi J; Nguyen TT; Charman SA; McIntosh MP; Shackleford DM
    J Pharm Sci; 2012 Sep; 101(9):3381-9. PubMed ID: 22549698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.